drugset / Trial / NCT04960657
The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers
RandomizedCrossoverQuadruple-blindOther
Summary
To investigate the hemodynamic effects of PACAP38 after glibenclamide administration.
Timeline
- Start
- 2020-10-20
- Primary completion
- 2021-03-19
- Completion
- 2021-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glyburide | Small molecule | — | Oral |
| Comparator | PACAP38 | Peptide | — | — |